Trevi Therapeutics
TRVI
TRVI
53 hedge funds and large institutions have $117M invested in Trevi Therapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 5 closing their positions.
Holders
53
Holders Change
+17
Holders Change %
+47.22%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
16
Reduced
8
Closed
5
Calls
$47K
Puts
–
Net Calls
+$47K
Net Calls Change
+$133K
Top Buyers
1 |
1
BlackRock
New York
|
$5.34M |
2 |
OM
2
Opaleye Management
Boston,
Massachusetts
|
$4.07M |
3 |
3
State Street
Boston,
Massachusetts
|
$1.63M |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$1.86M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$4.57M |